Series Overview

The Committee on Infection (COI) meets monthly to review, discuss, and develop strategies related to infection prevention, surveillance, and control across Baystate Health. The educational focus of these sessions is to enhance interdisciplinary collaboration, promote evidence-based infection prevention practices, and ensure alignment with local, state, and federal guidelines. Through presentation and discussion of case studies, policy updates, and outcome data, participants gain a deeper understanding of emerging infectious threats, regulatory changes, and hospital-acquired infection trends. The goal is to strengthen the healthcare team’s ability to implement effective prevention strategies, respond to outbreaks, and improve patient safety across the health system.

Intended Audience

Physician, Nurse, Advanced practitioners, Pharmacists, Department of Quality professionals

Planning Committee

Accreditation

Accreditation Statement

In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 
 

Physicians (AMA) Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM.  Physicians should only claim the credit commensurate with the extent of their participation in the activity.

Risk Management  This activity meets the criteria for 1.5 hours(s) in Risk Management study.  This activity meets the Massachusetts Board of Registration in Medicine criteria for Risk Management credit by addressing system-based infection prevention strategies, regulatory compliance, and measures to reduce patient harm and improve safety outcomes.

American Nurses Credentialing Center (ANCC) Baystate Continuing Interprofessional Education designates this live activity for a maximum of 1.5 contact hour(s).  Nurses should only claim the credit commensurate with the extent of their participation in the activity.

AAPA Credit Designation Statement  AAPA accepts AMA category 1 credit for the PRA from organizations accredited by ACCME.  Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.  This activity is designated for 1.5 AAPA Category 1 CME credit(s).  PA’s should only claim credit commensurate with the extent of their participation.

Pharmacists Baystate Health designates this activity for a maximum of 1.5 contact hour(s) for pharmacists. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity.

This activity was planned by and for the healthcare team and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

POLICY ON FACULTY AND SPONSOR DISCLOSURE

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Any relevant financial relationships are mitigated prior to the educational activity.

None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.                                                                  

Series location: 
Via Zoom

Global Objectives: 

As a result of participation in this educational series, members of the healthcare team will be able to:

1. Interpret infection prevention and control data to identify trends, opportunities for improvement, and emerging areas of concern.
2. Apply current evidence-based practices, regulatory standards, and institutional policies to reduce healthcare-associated infections (HAIs) and improve patient safety.
3. Evaluate infection prevention strategies across various clinical settings to promote consistency and compliance with national guidelines.
4. Collaborate with interprofessional teams to address system-level barriers, implement corrective actions, and monitor outcomes related to infection prevention.
5. Integrate new tools, technologies, and process improvement initiatives that enhance surveillance, reporting, and response to infection-related issues.

Interprofessional RSS:
Yes

Intended Audience: 
Nurse
Physician
Pharmacists

Credits Available:
AMA PRA Category 1 Credit™
ANCC Contact Hours
ACPE
IPCE